Longitudinal Analysis of Antibody Response Following SARS-CoV-2 Infection Depending on Disease Severity: A Prospective Cohort Study.

Christina ZirouSentiljana Gumeni Ioannis Bellos Ioannis Ntanasis-Stathopoulos Aimilia D SklirouTina BagratuniEleni KorompokiFilia ApostolakouIoannis Papassotiriou Ioannis P Trougakos Evangelos Terpos

Published in: Viruses (2023)

Severe COVID-19 is associated with higher anti-RBD and neutralizing antibodies up to 6 months after the infection. Vaccination of recovered patients is associated with a remarkable augmentation of antibody titers up to one year after COVID-19 diagnosis, regardless of disease severity.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
respiratory syndrome coronavirus
early onset
cross sectional
patient reported